FDA
approval
· 2023-07-31
FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
Summary
The FDA approves Accord Healthcare, Inc.'s supplemental application for simvastatin (ANDA 078155), authorizing the continued marketing of this generic statin un…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SIMVASTATIN (SIMVASTATIN)